View Older Stories View More Recent Stories
-
MMI Expands Global Footprint with Entry into Asia Pacific Market
-
Late-Breaking Data Confirms Safety of Axon Therapies' Innovative Heart Failure Procedure and Identifies Patients Most Likely to Benefit from SAVM Therapy
-
Aviko Radiopharmaceuticals and Neutron Therapeutics Form Exclusive, Strategic Partnership with Leo Cancer Care to Expand Development of Boron Neutron Capture Therapy for Treating Cancer
-
Adela Announces $48 Million in Financing and Leadership Addition to Advance Tissue-Agnostic Minimal Residual Disease (MRD) Monitoring Product Portfolio Based on Genome-Wide Methylome Approach
-
MMI’s Symani® Robotic Surgical System Surpasses 500 Clinical Procedures
-
Cure® Makes Commitment with Clinton Global Initiative to Advance Healthcare Through Partnerships Acting on Pressing Global Health Challenges and Opportunities
-
Actio Biosciences Announces $55 Million Series A Financing to Advance Precision Medicine Approach for Rare and Common Diseases
-
Cure® to Host Science Summit of 78th United Nations General Assembly
-
Endologix announces the U. S. Centers for Medicare & Medicaid Services granted a New Technology Add-on Payment for the DETOUR System
-
Endologix Announces that Lucas Buchanan Joins Board of Directors
-
Valneva Announces Extension of Existing Loan Agreement
-
Form 13F-HR DEERFIELD MANAGEMENT For: Jun 30
-
Form SC 13D/A DA32 Life Science Tech Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
End in sight for U.S. insider trading case over healthcare leaks
-
Octave Bioscience Closes $30M Extension to Series B Funding
-
Endologix Announces First Patients Treated with the DETOUR™ System, Advancing Treatment for Complex Peripheral Artery Disease
-
Presidio Medical™ Announces $72M Equity Fundraising Led by Deerfield
-
cystetic Medicines Initiates Phase 1 Clinical Trial of a Molecular Prosthetic for Cystic Fibrosis
-
Form 4 Acutus Medical, Inc. For: Jun 16 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Form 4 Nuvalent, Inc. For: Jun 15 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Endologix Announces 24-Month Results of DETOUR-2 Study at 2023 Vascular Annual Meeting
-
LSI USA Emerging Medtech Summit Returns to Dana Point March 18, 2024
-
Adaptive Phage Therapeutics Closes on $12 Million Investment in $30 Million Series B1 to Fight Antibiotic Resistant Infections
-
Form 4 CareMax, Inc. For: Jun 08 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Deerfield Management and the Deerfield Foundation Announce the Creation of the American Society of Hematology (ASH) Peter Steelman Scholar Award and the First Annual AML Summit to Advance Research for
-
Endologix Receives FDA Approval of the DETOUR™ System to Treat Long Complex Superficial Femoropopliteal Lesions in Patients with PAD
-
Aviko Radiopharmaceuticals and Neutron Therapeutics Form Strategic Partnership to Advance Boron Neutron Capture Therapy
-
Bitterroot Bio Launches Out of Stealth with $145 Million Series A Financing to Develop Transformative Medicines in Cardio-immunology
-
NYU Langone Health and Deerfield Management Launch Amethyst Innovations with Up To $130 Million to Accelerate Commercialization of Biomedical Discoveries
-
Adaptive Phage Therapeutics Enters Collaboration and License Agreement with Hebrew University of Jerusalem and Hadassah Medical Center
-
Element Science Announces Completion of Enrollment in the Jewel IDE Study Evaluating the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)
-
Endologix Announces 150th Patient Enrolled in JAGUAR Randomized Controlled Trial
-
Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases
-
4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases
-
Form 13F-HR DEERFIELD MANAGEMENT For: Mar 31
-
Form 4 Larimar Therapeutics, For: May 09 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Adela Announces Appointment of Alan Williams as Chief Operating Officer
-
Deerfield Management-Founded Aviko Radiopharmaceuticals to Advance Precision Boron Neutron Capture Therapy to Treat Cancer and Other Diseases
-
Element Science Adds Kathy Jeffery as Chief People Officer
-
Gene & cell therapy manufacturing specialist Ascend launches with over $130M of funding as expert teams merge
-
Endologix Wins “Medical Device Engineering Breakthrough” Award in 7th Annual MedTech Breakthrough Awards Program
-
Five-Year Results of the LEOPARD Trial published in the Journal of Vascular Surgery (JVS)
-
Cortica Closes $75 Million in New Funding Round and Acquires Springtide Child Development
-
Adela presents data demonstrating strong detection of 12 cancer types at the American Association for Cancer Research Annual Meeting 2023
-
Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC
-
Deerfield Management Announces 2023 XSeed Award Winners
-
Deerfield Management Announces $25M Grant from New York State and Empire State Development to Build a Lab of the Future at Healthcare Innovation Campus, Cure®
-
Valneva SE (VALN) Reports FY22 Revenue of EUR 361.3M, Loss of EUR 143.3M, Guides FY23 Revenue of EUR 220M-260M
-
Valneva Reports Full Year 2022 Results and Provides Corporate Updates
-
Valneva Reports Full Year 2022 Results and Provides Corporate Updates
